Covered recipient · General Payments record
SERENA ASHOUR
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2023–2024
$2,073.25
- Reported across 53 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,068.87 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $399.48 | 20 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $221.74 | 3 |
| Lilly USA, LLC | $137.38 | 3 |
| Biogen, Inc. | $116.79 | 2 |
| SK Life Science, Inc. | $92.59 | 2 |
| PFIZER INC. | $87.47 | 5 |
| Amgen Inc. | $13.42 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $9.03 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457476 | CMS |
| ABBVIE INC. | $24.48 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457478 | CMS |
| ABBVIE INC. | $7.73 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457480 | CMS |
| ABBVIE INC. | $14.97 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457482 | CMS |
| ABBVIE INC. | $8.08 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457484 | CMS |
| ABBVIE INC. | $11.19 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457486 | CMS |
| ABBVIE INC. | $6.73 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457488 | CMS |
| ABBVIE INC. | $96.96 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457490 | CMS |
| ABBVIE INC. | $13.44 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457492 | CMS |
| ABBVIE INC. | $25.72 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457494 | CMS |
| ABBVIE INC. | $6.85 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457496 | CMS |
| ABBVIE INC. | $12.77 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457498 | CMS |
| ABBVIE INC. | $28.38 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457500 | CMS |
| ABBVIE INC. | $29.85 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457502 | CMS |
| ABBVIE INC. | $17.21 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457504 | CMS |
| ABBVIE INC. | $26.04 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457506 | CMS |
| ABBVIE INC. | $24.84 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457508 | CMS |
| ABBVIE INC. | $10.29 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457510 | CMS |
| ABBVIE INC. | $5.58 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457512 | CMS |
| ABBVIE INC. | $19.34 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106457514 | CMS |
| Amgen Inc. | $13.42 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117193155 | CMS |
| Biogen, Inc. | $100.00 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104863906 | CMS |
| Biogen, Inc. | $16.79 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104805629 | CMS |
| Lilly USA, LLC | $11.50 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135887513 | CMS |
| Lilly USA, LLC | $15.06 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135943518 | CMS |
| Lilly USA, LLC | $110.82 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135949312 | CMS |
| Novartis Pharmaceuticals Corporation | $111.19 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086753583 | CMS |
| Novartis Pharmaceuticals Corporation | $10.49 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086753585 | CMS |
| Novartis Pharmaceuticals Corporation | $100.06 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086753587 | CMS |
| PFIZER INC. | $17.70 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131175415 | CMS |
| PFIZER INC. | $13.94 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131476949 | CMS |
| PFIZER INC. | $17.05 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131650666 | CMS |
| PFIZER INC. | $14.89 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131844792 | CMS |
| PFIZER INC. | $23.89 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132077393 | CMS |
| SK Life Science, Inc. | $71.12 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154132109 | CMS |
| SK Life Science, Inc. | $21.47 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154132141 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.